PATENT CLAIM ANALYSIS

Application Number: 16127776
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["546", "278400"]

Abstract:
Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

Claim (Index 29):
The compound of  claim 20 , wherein the compound is: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 97.0
- Lexical Diversity: 1.27273
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14776603', '14776715', '13815770', '14776717', '14207289']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.786368062248975
- 35 USC 102 Novelty (BERT): 0.505899992192537
- Combined Prediction Score: 0.7583212552433313
- Mean Citation Score: 259.508378
- Max Citation Score: 267.74744
- Similarity Product: 204.90082152932644

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test